2017 | Erdheim-Chester Disease Global Alliance

The ECD Global Alliance Welcomes Israel ECD Referral Care Center

The ECD Global Alliance Welcomes Israel ECD Referral Care Center

31 Δεκεμβρίου 2017

Assuta Medical Center joins an elite group of hospitals skilled in treating Erdheim-Chester disease patients.

Care Network Serves Australian Rare Disease Patients

Care Network Serves Australian Rare Disease Patients

31 Δεκεμβρίου 2017

The Erdheim-Chester Disease Global Alliance is proud to announce the first ECD Referral Care Center to be located in Australia.

FDA Approves Zelboraf (Vemurafenib) for Erdheim-Chester Disease with BRAF V600 Mutation

FDA Approves Zelboraf (Vemurafenib) for Erdheim-Chester Disease with BRAF V600 Mutation

31 Δεκεμβρίου 2017

First FDA-Approved drug for this rare disease

December 9, 2017

10 Φεβρουαρίου 2017

November 18, 2017

10 Φεβρουαρίου 2017

« Παλαιότερες καταχωρήσεις

Επόμενες καταχωρήσεις »